Evidence map›Paper›PMID 32593567›Full record

ArticleAnaerobe2020

COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients.

Patrizia Spigaglia

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Anaerobe, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04854941 (Efficacy of Probiotics), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04854941 nacompletednot on this map

Efficacy of Probiotics (Lactobacillus Rhamnosus, Bifidobacterium Bifidum, Bifidobacterium Longum Subsp. Infantis and Bifidobacterium Longum) in the Treatment of Hospitalised Patients With Novel Coronavirus Infection

TypeinterventionalSponsorI.M. Sechenov First Moscow State Medical UniversityRan2020 to 2021Enrolled200ConditionsCoronavirus InfectionArmsProbiotics
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Future microbiology · 2024
    Observational
  4. Article
  5. Article
  6. Microorganisms · 2022
    Article
  7. Article
  8. Characterization ofMicroorganisms · 2022
    Article
  9. Article
  10. Risk Factors for Hospital Readmission forPathogens (Basel, Switzerland) · 2022
    Article
  11. Antibiotic prescribing patterns among patients admitted to an academic teaching hospital for COVID-19 during the first wave of the pandemic in Toronto: A retrospective, controlled study.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
  12. Frontiers in medicine · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Patrizia SpigagliaDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides difficile (ESGCD), Italy. Electronic address: patrizia.spigaglia@iss.it.
Istituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 dramatically affects the elderly. Due to the large usage of antibiotics during the current pandemic and the gastrointestinal manifestations of COVID-19, the elderly population, hospitalized patients, residents in LTCFs and persons that survived the COVID-19 might be more prone to Clostridioides difficile infections (CDI). A renewed attention to CDI is necessary during the ongoing COVID-19 pandemic.

Indexed as

AgedAged, 80 and overAnti-Bacterial AgentsBetacoronavirusClostridioides difficileClostridium InfectionsCoronavirus InfectionsCOVID-19GastroenteritisGastrointestinal TractHumansPandemicsPneumonia, ViralSARS-CoV-2Anti-Bacterial AgentsAntibioticCDIC. difficileCOVID-19ElderlyGastrointestinal symptoms

Identifiers

PMID32593567
PMCPMC7315154
OpenAlexW3038068793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.